Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-Mediated Type 1 Diabetes: PDCs Augment Th1 responses through IFN-α production

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1024-1034

  Xia, Chang Qing ^a   Peng, Ruihua ^a   Chernatynskaya, Anna V ^a   Yuan, Lihui ^a   Carter, Carolyn ^a   Valentine, John ^a   Sobel, Eric ^a   Atkinson, Mark A ^a   Clare Salzler, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; INTERFERON; INTERFERON ALPHABETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS B4; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLUENZA VIRUS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; TH1 CELL;

ADOLESCENT; ADULT; BLOOD CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; ORTHOMYXOVIRIDAE; TH1 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84906085028     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303230     Document Type: Article

References (71)

1. Shoda, L. K., D. L. Young, S. Ramanujan, C. C. Whiting, M. A. Atkinson, J. A. Bluestone, G. S. Eisenbarth, D. Mathis, A. A. Rossini, S. E. Campbell, et al. 2005. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23: 115-126.
2. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297.
3. Atkinson, M. A., and R. Gianani. 2009. The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr. Opin. Endocrinol. Diabetes Obes. 16: 279-285.
4. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221-229.
5. Fourlanos, S., L. C. Harrison, and P. G. Colman. 2008. The accelerator hypothesis and increasing incidence of type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 15: 321-325.
6. Zipris, D. 2008. Innate immunity and its role in type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 15: 326-331.
7. Eizirik, D. L., M. L. Colli, and F. Ortis. 2009. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5: 219-226.
8. Lien, E., and D. Zipris. 2009. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 9: 52-68.
9. Bonjardim, C. A. 2005. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses-and viruses counteract IFN action. Microbes Infect. 7: 569-578.
10. Tough, D. F. 2004. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk. Lymphoma 45: 257-264.
11. Le Bon, A., and D. F. Tough. 2008. Type I interferon as a stimulus for crosspriming. Cytokine Growth Factor Rev. 19: 33-40.
12. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
13. Longhi, M. P., C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman. 2009. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206: 1589-1602.
14. Nguyen, K. B., W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O'Shea, and C. A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297: 2063-2066.
15. Biron, C. A. 1998. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10: 383-390.
16. de Waal Malefyt, R. 1997. The role of type I interferons in the differentiation and function of Th1 and Th2 cells. Semin. Oncol. 24: S9-94-S9-98.
17. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
18. Schreuder, T. C., H. C. Gelderblom, C. J. Weegink, D. Hamann, H. W. Reesink, J. H. Devries, J. B. Hoekstra, and P. L. Jansen. 2008. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. Liver Int. 28: 39-46.
19. Bosi, E., R. Minelli, E. Bazzigaluppi, and M. Salvi. 2001. Fulminant autoimmune type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabet. Med. 18: 329-332.
20. Liu, Y. J., N. Kadowaki, M. C. Rissoan, and V. Soumelis. 2000. T cell activation and polarization by DC1 and DC2. Curr. Top. Microbiol. Immunol. 251: 149-159.
21. Fabris, P., C. Betterle, N. A. Greggio, R. Zanchetta, E. Bosi, M. R. Biasin, and F. de Lalla. 1998. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J. Hepatol. 28: 514-517.
22. Alba, A., M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi. 2004. IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice. J. Immunol. 173: 6667-6675.
23. Li, Q., B. Xu, S. A. Michie, K. H. Rubins, R. D. Schreriber, and H. O. McDevitt. 2008. Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 105: 12439-12444.
24. Peng, R. H., E. Paek, C. Q. Xia, N. Tennyson, and M. J. Clare-Salzler. 2006. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice. Ann. N. Y. Acad. Sci. 1079: 99-102.
25. Ferreira, R. C., H. Guo, R. M. Coulson, D. J. Smyth, M. L. Pekalski, O. S. Burren, A. J. Cutler, J. D. Doecke, S. Flint, E. F. McKinney, et al. 2014. A type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes. Diabetes. DOI: 10.1002/jbm.b.33195.
26. Kallionpää, H., L. L. Elo, E. Laajala, J. Mykkänen, I. Ricaño-Ponce, M. Vaarma, T. D. Laajala, H. Hyöty, J. Ilonen, R. Veijola, et al. 2014. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes. DOI: 10.2337/db13-1775.
27. Kadowaki, N., and Y. J. Liu. 2002. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol. 63: 1126-1132.
28. Liu, Y. J. 2002. Uncover the mystery of plasmacytoid dendritic cell precursors or type 1 interferon producing cells by serendipity. Hum. Immunol. 63: 1067-1071.
29. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
30. Ito, T., Y. H. Wang, and Y. J. Liu. 2005. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin. Immunopathol. 26: 221-229.
31. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
32. Honda, K., Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040.
33. Richardson, S. J., A. Willcox, A. J. Bone, A. K. Foulis, and N. G. Morgan. 2009. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52: 1143-1151.
34. Devendra, D., and G. S. Eisenbarth. 2004. Interferon alpha- A potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin. Immunol. 111: 225-233.
35. Wang, J. P., D. R. Asher, M. Chan, E. A. Kurt-Jones, and R. W. Finberg. 2007. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J. Immunol. 178: 3363-3367.
36. Li, Q., and H. O. McDevitt. 2011. The role of interferon alpha in initiation of type I diabetes in the NOD mouse. Clin. Immunol. 140: 3-7.
37. Diana, J., Y. Simoni, L. Furio, L. Beaudoin, B. Agerberth, F. Barrat, and A. Lehuen. 2013. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 19: 65-73.
38. Xia, C. Q., and K. J. Kao. 2002. Heparin induces differentiation of CD1a+ dendritic cells from monocytes: phenotypic and functional characterization. J. Immunol. 168: 1131-1138.
39. Arpinati, M., C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti. 2000. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95: 2484-2490.
40. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186.
41. Shodell, M., and F. P. Siegal. 2002. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand. J. Immunol. 56: 518-521.
42. Drozina, G., J. Kohoutek, N. Jabrane-Ferrat, and B. M. Peterlin. 2005. Expression of MHC II genes. Curr. Top. Microbiol. Immunol. 290: 147-170.
43. Villadangos, J. A., P. Schnorrer, and N. S. Wilson. 2005. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207: 191-205.
44. Dalod, M., R. Chelbi, B. Malissen, and T. Lawrence. 2014. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J. 33: 1104-1116.
45. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311: 17-58.
46. Münz, C., R. M. Steinman, and S. Fujii. 2005. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202: 203-207.
47. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294: 1540-1543.
48. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723.
49. Gray, R. C., J. Kuchtey, and C. V. Harding. 2007. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I crosspresentation in DCs as effectively as CpG-A and CpG-C ODNs. J. Leukoc. Biol. 81: 1075-1085.
50. Allen, J. S., K. Pang, A. Skowera, R. Ellis, C. Rackham, B. Lozanoska-Ochser, T. Tree, R. D. Leslie, J. M. Tremble, C. M. Dayan, and M. Peakman. 2009. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes 58: 138-145.
51. Lau-Kilby, A. W., C. C. Kretz, S. Pechhold, J. D. Price, S. Dorta, H. Ramos, G. Trinchieri, and K. V. Tarbell. 2011. Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 108: 2408-2413.
52. Goudy, K. S., M. C. Johnson, A. Garland, C. Li, R. J. Samulski, B. Wang, and R. Tisch. 2011. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity. Eur. J. Immunol. 41: 1480-1490.
53. Garg, G., J. R. Tyler, J. H. Yang, A. J. Cutler, K. Downes, M. Pekalski, G. L. Bell, S. Nutland, M. Peakman, J. A. Todd, et al. 2012. Type 1 diabetesassociated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J. Immunol. 188: 4644-4653.
54. Chehadeh, W., J. Weill, M. C. Vantyghem, G. Alm, J. Lefèbvre, P. Wattré, and D. Hober. 2000. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J. Infect. Dis. 181: 1929-1939.
55. Krug, A., A. Towarowski, S. Britsch, S. Rothenfusser, V. Hornung, R. Bals, T. Giese, H. Engelmann, S. Endres, A. M. Krieg, and G. Hartmann. 2001. Tolllike receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31: 3026-3037.
56. Bendriss-Vermare, N., S. Burg, H. Kanzler, L. Chaperot, T. Duhen, O. de Bouteiller, M. D'agostini, J. M. Bridon, I. Durand, J. M. Sederstrom, et al. 2005. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFNgamma and Th1 chemokine production. J. Leukoc. Biol. 78: 954-966.
57. Foulis, A. K., M. A. Farquharson, and A. Meager. 1987. Immunoreactive alphainterferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 2: 1423-1427.
58. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M. T. Fernández-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Martí, D. Jaraquemada, and R. Pujol-Borrell. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153: 1360-1377.
59. Levy, H., X. Wang, M. Kaldunski, S. Jia, J. Kramer, S. J. Pavletich, M. Reske, T. Gessel, M. Yassai, M. W. Quasney, et al. 2012. Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes. Genes Immun. 13: 593-604.
60. Chen, Y. G., S. M. Cabrera, S. Jia, M. L. Kaldunski, J. Kramer, S. Cheong, R. Geoffrey, M. F. Roethle, J. E. Woodliff, C. J. Greenbaum, et al. 2014. Molecular signatures differentiate immune states in type 1 diabetes families. Diabetes. DOI: 10.2337/db14-0214.
61. Su, D. L., Z. M. Lu, M. N. Shen, X. Li, and L. Y. Sun. 2012. Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. J. Biomed. Biotechnol. 2012: 347141.
62. Karageorgas, T. P., D. D. Tseronis, and C. P. Mavragani. 2011. Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes. J. Biomed. Biotechnol. 2011: 273907.
63. Rönnblom, L., G. V. Alm, and M. L. Eloranta. 2011. The type I interferon system in the development of lupus. Semin. Immunol. 23: 113-121.
64. Blom, B., S. Ho, S. Antonenko, and Y. J. Liu. 2000. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J. Exp. Med. 192: 1785-1796.
65. Liu, Y. J., and B. Blom. 2000. Introduction: TH2-inducing DC2 for immunotherapy. Blood 95: 2482-2483.
66. Liu, Y. J., H. Kanzler, V. Soumelis, and M. Gilliet. 2001. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2: 585-589.
67. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
68. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
69. Ivakine, E. A., O. M. Gulban, S. M. Mortin-Toth, E. Wankiewicz, C. Scott, D. Spurrell, A. Canty, and J. S. Danska. 2006. Molecular genetic analysis of the Idd4 locus implicates the IFN response in type 1 diabetes susceptibility in nonobese diabetic mice. J. Immunol. 176: 2976-2990.
70. Liu, S., H. Wang, Y. Jin, R. Podolsky, M. V. Reddy, J. Pedersen, B. Bode, J. Reed, D. Steed, S. Anderson, et al. 2009. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 18: 358-365.
71. Nejentsev, S., N. Walker, D. Riches, M. Egholm, and J. A. Todd. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324: 387-389.